Education
About Us
Working with TipRanks
Follow Us
Eastwood Bio-Medical Canada (TSE:EBM)
:EBM
RESEARCH TOOLSreports
EBM Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$0.30 - C$1.15
Previous CloseN/A
Volume2.20K
Average Volume (3M)3.33K
Market Cap
C$30.31M
Enterprise ValueC$33.13M
Total Cash (Recent Filing)C$18.96K
Total Debt (Recent Filing)C$80.15K
Price to Earnings (P/E)―
Beta-1.53
Next Earnings
Sep 25, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding68,885,970
10 Day Avg. Volume3,250
30 Day Avg. Volume3,334
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EBM FAQ
What was Eastwood Bio-Medical Canada’s price range in the past 12 months?
Eastwood Bio-Medical Canada lowest stock price was C$0.29 and its highest was C$1.15 in the past 12 months.
What is Eastwood Bio-Medical Canada’s market cap?
Eastwood Bio-Medical Canada’s market cap is C$30.31M.
When is Eastwood Bio-Medical Canada’s upcoming earnings report date?
Eastwood Bio-Medical Canada’s upcoming earnings report date is Sep 25, 2025 which is in 6 days.
How were Eastwood Bio-Medical Canada’s earnings last quarter?
Eastwood Bio-Medical Canada released its earnings results on Jun 30, 2025. The company reported -C$0.002 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.002.
Is Eastwood Bio-Medical Canada overvalued?
According to Wall Street analysts Eastwood Bio-Medical Canada’s price is currently Overvalued.
Does Eastwood Bio-Medical Canada pay dividends?
Eastwood Bio-Medical Canada does not currently pay dividends.
What is Eastwood Bio-Medical Canada’s EPS estimate?
Eastwood Bio-Medical Canada’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Eastwood Bio-Medical Canada have?
Eastwood Bio-Medical Canada has 68,885,970 shares outstanding.
What happened to Eastwood Bio-Medical Canada’s price movement after its last earnings report?
Eastwood Bio-Medical Canada reported an EPS of -C$0.002 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Eastwood Bio-Medical Canada?
Currently, no hedge funds are holding shares in TSE:EBM
Company Description
Eastwood Bio-Medical Canada
Eastwood Bio-Medical Canada Inc. markets and distributes natural health products under the Eleotin brand in Canada, the United States, and Asia. It distributes Eleotin that provide natural remedies for metabolic disorders, such as blood glucose disorders, hypertension, and obesity. The company's licensed products include Eleotin A 700 for the treatment for spleen deficiency, lack of appetite, and fatigue; Eleotin AL88 for laxative; Eleotin Cal20 for bone and teeth maintenance; Eleotin V3D for development and maintenance of bones, teeth, and good health; Eleotin G2000 for cardiovascular health; Eleotin H55 for sedative and tension relief; and Eleotin Zn330 for tissue formation and metabolism. Its products also include Eleotin Bentley to promote healthy glucose levels; and Eleotin LBM for hypertension relief. The company was incorporated in 2010 and is based in Richmond, Canada.
Technical Analysis
Diagnos
―
Reliq Health Technologies
―
Sona Nanotech Inc
―
Devonian Health Group
―
Zoglo's Incredible Food Corp.
―
Options Prices
Currently, No data available
---